Citigroup’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.6M | Sell |
70,707
-63,014
| -47% | -$3.21M | ﹤0.01% | 1631 |
|
2025
Q1 | $6.02M | Sell |
133,721
-72
| -0.1% | -$3.24K | ﹤0.01% | 1263 |
|
2024
Q4 | $5.53M | Sell |
133,793
-17,700
| -12% | -$732K | ﹤0.01% | 1333 |
|
2024
Q3 | $5.91M | Sell |
151,493
-61,011
| -29% | -$2.38M | ﹤0.01% | 1232 |
|
2024
Q2 | $7.27M | Sell |
212,504
-158,547
| -43% | -$5.42M | ﹤0.01% | 1013 |
|
2024
Q1 | $9.32M | Buy |
371,051
+285,820
| +335% | +$7.18M | 0.01% | 925 |
|
2023
Q4 | $2.52M | Buy |
85,231
+26,508
| +45% | +$783K | ﹤0.01% | 1487 |
|
2023
Q3 | $1.86M | Buy |
58,723
+17,917
| +44% | +$566K | ﹤0.01% | 1515 |
|
2023
Q2 | $1.06M | Sell |
40,806
-28,571
| -41% | -$739K | ﹤0.01% | 2209 |
|
2023
Q1 | $1.67M | Sell |
69,377
-98,196
| -59% | -$2.36M | ﹤0.01% | 1650 |
|
2022
Q4 | $3.27M | Buy |
167,573
+29,407
| +21% | +$573K | ﹤0.01% | 1257 |
|
2022
Q3 | $2.9M | Buy |
138,166
+136,395
| +7,702% | +$2.87M | ﹤0.01% | 1387 |
|
2022
Q2 | $34K | Buy |
1,771
+966
| +120% | +$18.5K | ﹤0.01% | 4029 |
|
2022
Q1 | $18K | Sell |
805
-1,039
| -56% | -$23.2K | ﹤0.01% | 4466 |
|
2021
Q4 | $29K | Buy |
1,844
+1,433
| +349% | +$22.5K | ﹤0.01% | 4514 |
|
2021
Q3 | $8K | Buy |
411
+240
| +140% | +$4.67K | ﹤0.01% | 4762 |
|
2021
Q2 | $3K | Sell |
171
-228
| -57% | -$4K | ﹤0.01% | 5241 |
|
2021
Q1 | $8K | Sell |
399
-672
| -63% | -$13.5K | ﹤0.01% | 5095 |
|
2020
Q4 | $19K | Buy |
1,071
+821
| +328% | +$14.6K | ﹤0.01% | 4651 |
|
2020
Q3 | $5K | Sell |
250
-498
| -67% | -$9.96K | ﹤0.01% | 4669 |
|
2020
Q2 | $15K | Buy |
748
+154
| +26% | +$3.09K | ﹤0.01% | 4428 |
|
2020
Q1 | $8K | Buy |
594
+54
| +10% | +$727 | ﹤0.01% | 4692 |
|
2019
Q4 | $13K | Buy |
540
+421
| +354% | +$10.1K | ﹤0.01% | 4635 |
|
2019
Q3 | $2K | Buy |
+119
| New | +$2K | ﹤0.01% | 4961 |
|